In this study, we report that a CAER platform using autologous ERs as INS-carriers and GOx expressed on the surface of the cells to function as a glucose-activated switch could accomplish glycemic control and hemodialysis for diabetes mellitus therapy. The gene discussed is INS; the disease is diabetes mellitus.